MedPath

HYDROMORPHONE HYDROCHLORIDE INJECTION, USP

HYDROMORPHONE HYDROCHLORIDE INJECTION, USP

Approved
DIN Number

02491680

Drug Class

Human

Market Date

Nov 10, 2020

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02491680
AIG Number0108698001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA03 HYDROMORPHONE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Intravenous ,  Subcutaneous
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

HYDROMORPHONE HYDROCHLORIDEActive
Strength: 10 MG / ML
Monograph: HYDROMORPHONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.